Bioaltus Pharmaceuticals Private Limited - Company Profile

It is a pharma private limited company based in Thane West, Maharashtra, India, established in 2014.
2014 Thane West, Maharashtra, India Active
Last Updated:
Access Report
About Bioaltus Pharmaceuticals Private Limited

Bioaltus Pharmaceuticals Private Limited, a active private limited company, was established on 21 March 2014 in Thane West, Maharashtra, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U74900MH2014PTC254786. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹1.00 Cr and a paid-up capital of ₹9.29 M.

It upholds a compliant status. Employing 33 professional, Its leadership includes Ankit Varshney (Whole-Time Director), Gopinath Ramankutty Nair (Whole-Time Director). Past directors included Ankit Varshney, Devanshi Vijay Doshi, Mehul Pravin Shah. It holds ₹65.00 Cr open charges and ₹15.72 Cr settled loans. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at First Floor,Office No. 25-28, Tl 5, Morning Glory, Tropical Lagoon Phase Iii, Kavesar,Ghodb, Under Road, Thane West, Maharashtra, 400615.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U74900MH2014PTC254786

  • Registration Number

    254786

  • Incorporation Date

    21 March 2014

  • Authorized Capital

    ₹1.00 Cr

  • Paid-Up Capital

    ₹9.29 M

  • ROC Code

    Roc Mumbai

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 1.00 Cr
  • Paid Up Capital ₹ 9.29 M
  • Company Age 11 Year, 11 Months
  • Last Filing with ROC 31 Mar 2025
  • Open Charges ₹ 65.00 Cr
  • Satisfied Charges ₹ 15.72 Cr
  • Revenue Growth **** 52.30%
  • Profit Growth **** 314.60%
  • Ebitda **** 159.19%
  • Net Worth 44.80%
  • Total Assets **** 64.79%
Company report

Bioaltus Pharmaceuticals Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Bioaltus Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Bioaltus Pharmaceuticals Private Limited?
Current Directors
Name Designation Appointment Date Status
Ankit Varshney Whole-Time Director 21 Mar 2014 Current
Gopinath Ramankutty Nair Whole-Time Director 18 Aug 2014 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 06 Jan 2016 Past
Pramod Abcsdd Additional Director 30 Sep 2022 Past
Pramod Abcsdd Director 25 Aug 2022 Past
Pramod Abcsdd Director 06 Jan 2016 Past
Pramod Abcsdd Director 05 Jan 2016 Past
Pramod Abcsdd Director 06 Jan 2016 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Bioaltus Pharmaceuticals.

Bioaltus Pharmaceuticals Private Limited, for the financial year ended 2024, experienced significant growth in revenue, with a 52.3% increase. The company also saw a substantial improvement in profitability, with a 314.6% increase in profit. The company's net worth Soared by an impressive increase of 44.8%.

Bioaltus Pharmaceuticals revenue growth over time
Bioaltus Pharmaceuticals profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 52.30%
*******
*******
*******
*******
Revenue from Operations
*******
 52.13%
*******
*******
*******
*******
Total Assets
*******
 64.79%
*******
*******
*******
*******
Profit or Loss
*******
 314.60%
*******
*******
*******
*******
Net Worth
*******
 44.80%
*******
*******
*******
*******
EBITDA
*******
 159.19%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Bioaltus Pharmaceuticals?

In 2024, Bioaltus Pharmaceuticals had a promoter holding of 100.00%. The company had 1 Subsidiary. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹650,000,000.00

Satisfied Charges

₹157,197,709.60

Charges Breakdown by Lending Institutions
  • Hdfc Bank Limited : 65.00 Cr
Latest Charge Details
Date Lender Amount Status
15 May 2025 Hdfc Bank Limited ₹65.00 Cr Open
31 Dec 2022 State Bank Of India ₹7.50 Cr Satisfied
13 Jan 2022 Others ₹5.00 M Satisfied
19 May 2020 Others ₹4.00 Cr Satisfied
28 Sep 2018 Others ₹3.00 Cr Satisfied

Explore comprehensive loan charge details -

How Many Employees Work at Bioaltus Pharmaceuticals?

Bioaltus Pharmaceuticals has a workforce of 33 employees as of Mar 31, 2025. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Bioaltus Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Bioaltus Pharmaceuticals's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Bioaltus Pharmaceuticals
Recent Activity within the Organization
  • Annual General Meeting

    The activity Bioaltus Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was completed.

  • Charges

    Progress on A charge with Hdfc Bank Limited of Rs. 65.00 Cr registered on 15 May 2025 with Charge ID 101107796 was modified on 08 Jul 2025. was documented.

  • Charges

    A charge registered on 31 Dec 2022 via Charge ID 100673869 with State Bank Of India was fully satisfied on 20 May 2025. was recorded as a recent event.

  • Charges

    A charge with Hdfc Bank Limited amounted to Rs. 65.00 Cr with Charge ID 101107796 was registered on 15 May 2025. was recorded as a recent event.

  • Balance Sheet

    Progress on Bioaltus Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai. was documented.

  • Charges

    Progress on A charge with State Bank Of India amounted to Rs. 7.50 Cr with Charge ID 100673869 was registered on 31 Dec 2022. was documented.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Bioaltus Pharmaceuticals Private Limited?

The CIN of Bioaltus Pharmaceuticals Private Limited is U74900MH2014PTC254786.

Where is Bioaltus Pharmaceuticals Private Limited headquartered?

Bioaltus Pharmaceuticals Private Limited is headquartered at First Floor,Office No. 25-28, Tl 5, Morning Glory, Tropical Lagoon Phase Iii, Kavesar,Ghodb, Under Road, Thane West, Maharashtra, 400615.

When was Bioaltus Pharmaceuticals Private Limited incorporated?

Bioaltus Pharmaceuticals Private Limited was incorporated on 21 March 2014.

Who are the current directors of Bioaltus Pharmaceuticals Private Limited?

The current directors of Bioaltus Pharmaceuticals Private Limited are

What is the primary industry of Bioaltus Pharmaceuticals Private Limited?

The primary industry of Bioaltus Pharmaceuticals Private Limited is Manufacturing.

Is Bioaltus Pharmaceuticals Private Limited a listed company?

Bioaltus Pharmaceuticals Private Limited is unlisted.

What is the capital structure of Bioaltus Pharmaceuticals Private Limited?

The authorized capital of Bioaltus Pharmaceuticals Private Limited is ₹1.00 Cr, and the paid-up capital is ₹9.29 M.

What is the compliance status of Bioaltus Pharmaceuticals Private Limited?

The compliance status of Bioaltus Pharmaceuticals Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available